Innocoll Drug Patent Portfolio
Innocoll owns 1 orange book drug protected by 6 US patents Given below is the list of Innocoll's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11400019 | Sustained release drug delivery systems with reduced impurities and related methods | 12 Jan, 2041 | Active |
| US11771624 | Sustained release drug delivery systems with reduced impurities and related methods | 12 Jan, 2041 | Active |
| US8153149 | Controlled delivery system | 15 Sep, 2025 | Active |
| US8153661 | Controlled delivery system | 15 Sep, 2025 | Active |
| US8753665 | Controlled delivery system | 15 Sep, 2025 | Active |
| US8846072 | Controlled delivery system | 15 Sep, 2025 | Active |
Latest Legal Activities on Innocoll's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Innocoll.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Post Issue Communication - Certificate of Correction | 13 Oct, 2023 | US11400019 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 10 Oct, 2023 | US8153149 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 10 Oct, 2023 | US8153661 |
|
Email Notification
Critical
| 03 Oct, 2023 | US11771624 |
| Recordation of Patent eGrant | 03 Oct, 2023 | US11771624 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 03 Oct, 2023 | US11771624 |
| Patent eGrant Notification | 03 Oct, 2023 | US11771624 |
| Mail Patent eGrant Notification | 03 Oct, 2023 | US11771624 |
|
Recordation of Patent Grant Mailed
Critical
| 03 Oct, 2023 | US11771624 |
|
Email Notification
Critical
| 15 Sep, 2023 | US11771624 |
|
Issue Notification Mailed
Critical
| 13 Sep, 2023 | US11771624 |
|
Application Is Considered Ready for Issue
Critical
| 18 Aug, 2023 | US11771624 |
| Dispatch to FDC | 18 Aug, 2023 | US11771624 |
|
Issue Fee Payment Verified
Critical
| 17 Aug, 2023 | US11771624 |
|
Issue Fee Payment Received
Critical
| 17 Aug, 2023 | US11771624 |
Innocoll's Family Patents
Innocoll drugs have patent protection in a total of 29 countries. It's US patent count contributes only to 25.7% of its total global patent coverage. 4 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Innocoll Drug List
Given below is the complete list of Innocoll's drugs and the patents protecting them.
1. Posimir
Posimir is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11400019 | Sustained release drug delivery systems with reduced impurities and related methods |
12 Jan, 2041
(16 years from now)
| Active |
| US11771624 | Sustained release drug delivery systems with reduced impurities and related methods |
12 Jan, 2041
(16 years from now)
| Active |
| US8153149 | Controlled delivery system |
15 Sep, 2025
(11 months from now)
| Active |
| US8153661 | Controlled delivery system |
15 Sep, 2025
(11 months from now)
| Active |
| US8753665 | Controlled delivery system |
15 Sep, 2025
(11 months from now)
| Active |
| US8846072 | Controlled delivery system |
15 Sep, 2025
(11 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Posimir's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List